UWS
CORT icon

Unique Wealth Strategies’s Corcept Therapeutics CORT Stock Holding History

Unique Wealth Strategies’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$810K Sell
9,315
-7,261
-44% -$438K 0.29% 84
2026
Q1 		$668K Buy
+16,576
New +$620K 0.27% 92

Other funds holding CORT

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Unique Wealth Strategies's CORT Position: Q2 2026 in Review

Unique Wealth Strategies reduced its Corcept Therapeutics (CORT) stake by 44% in Q2 2026, selling an estimated $438K and leaving 9,315 shares worth $810K. The position accounts for 0.29% of the portfolio, ranked #84.

Unique Wealth Strategies first reported a position in CORT in Q1 2026 and has held it in 2 quarters since. 43 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Unique Wealth Strategies held 9,315 shares of Corcept Therapeutics worth $810K as of Q2 2026.
  • Unique Wealth Strategies sold 7,261 Corcept Therapeutics shares in Q2 2026, an estimated $438K.
  • Corcept Therapeutics made up 0.29% of Unique Wealth Strategies's portfolio in Q2 2026, its #84 holding.
  • Unique Wealth Strategies first reported a position in Corcept Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 43 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Unique Wealth Strategies's 13F filing for Q2 2026, filed 15 Jul 2026.